Self-buffering capacity of a human sulfatase for central nervous system delivery
Abstract Direct delivery of therapeutic enzymes to the Central Nervous System requires stringent formulation design. Not only should the formulation design consider the delicate balance of existing ions, proteins, and osmolality in the cerebrospinal fluid, it must also provide long term efficacy and...
Enregistré dans:
Auteurs principaux: | Yi Wen, Nazila Salamat-Miller, Keethkumar Jain, Katherine Taylor |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1400d1c04e6a4582b16f39e102a5ed4b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Freeze–thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics
par: Keethkumar Jain, et autres
Publié: (2021) -
Acidity and buffering capacity of Iranian Woods
par: Ahmad Jahan latibari, et autres
Publié: (1997) -
Human sulfatase transiently and functionally active expressed in E. coli K12
par: Poutou-Piñales,Raúl A, et autres
Publié: (2010) -
The Discovery of the Buffer Capacity of Various Types of Polyelectrolyte Microcapsules
par: Alexey V. Dubrovskii, et autres
Publié: (2021) -
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
par: Mykhaylo Demydchuk, et autres
Publié: (2017)